Gemcitabine base
CAS: 95058-81-4
Ref. 3D-ND04237
2g | 136,00 € | ||
5g | 224,00 € | ||
10g | 344,00 € | ||
25g | 684,00 € | ||
50g | 1.042,00 € |
Informação sobre produto
- 2-Deoxy-2',2'-difluorocytidine4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one2'-Deoxy-2',2'-difluor o-D-cytidine2',2'-Difluoro-2'-deoxycytidine
- Gemcitabine
- Cytidine, 2′-deoxy-2′,2′-difluoro-
- LY 188011
- DDFC
- 2′-Deoxy-2′,2′-difluorocytidine
Gemcitabine is a prodrug that is converted to 5-fluorouracil (5FU) in the body. It has been shown to inhibit the growth of bladder and pancreatic cancer cells by interfering with the synthesis of DNA. Gemcitabine inhibits DNA replication by binding to the epidermal growth factor receptor, which leads to cell death. Gemcitabine also acts as a competitive inhibitor of deoxycytidine kinase, which prevents the formation of deoxycytidine monophosphate from deoxyuridine monophosphate, preventing DNA replication. In addition, gemcitabine can activate apoptosis in some tumor cells by increasing levels of intracellular free calcium, which leads to activation of enzymes such as phospholipases and proteases that degrade proteins, lipids, and nucleic acids.
Propriedades químicas
Consulta técnica sobre: 3D-ND04237 Gemcitabine base
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.